Scandinavian ChemoTech AB (publ) Executive Summary of Interim report Q3 January – September 2024
Third quarter · Net sales amounted to kSEK 1 499 (1 080) · Profit before tax amounted to kSEK -3 243 (-4 526) · Earnings per share amounted to SEK -0,14 (-0,33) · Cash flow from operating activities totaled to kSEK -5 567 (-4 649) Period 1 January - 30 September · Net sales amounted to kSEK 4 525 (2 315) · Profit before tax amounted to kSEK -10 550 (-15 943) · Earnings per share amounted to SEK -0,53 (-1,22) · Cash flow from operating activities totaled to kSEK -10 973 (-14 831) Important events during the quarter · Last day for trading with BTA was